ArticleQuantitative imaging in medicine and surgery2025
Assessing left atrial volume and function in dyslipidemia patients using three-dimensional speckle tracking imaging.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As a cardiovascular risk factor, dyslipidemia can impair cardiac function in the early stage. Left atrial (LA) volume and function changes are sensitive indicators, but traditional ultrasound is difficult to detect early changes. Three-dimensional speckle tracking imaging (3D-STI) provides a new method for evaluating LA function by analyzing myocardial motion with high precision. In this study, 3D-STI was used to evaluate the early LA volume and function in patients with different dyslipidemia, in order to provide a basis for early clinical intervention. Methods: A total of 102 patients with dyslipidemia treated at The Affiliated Hospital of Qingdao University were selected and divided into the high total cholesterol (TC) group, high triglyceride (TG) group, low high-density lipoprotein cholesterol (HDL-C) group, and mixed dyslipidemia group. Thirty healthy volunteers approximately matched for age and gender were selected as the control group. Subsequently, the LA volume indices including LA maximal volume index (LAVi Results: The differences in LAVi Conclusions: LA volume and function are adversely affected by dyslipidemia, especially in patients with mixed dyslipidemia. 3D-STI effectively evaluates LA volume and function in patients with different types of dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.